SCHEMBL9917093

SCHEMBL9917093

CCC(=O)C(CC(C)N1CCCCC1)(c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.50
GRIN2D O15399 2/20 0.50
GRIN1 Q05586 2/20 0.50
GRIN2A Q12879 2/20 0.50
GRIN2B Q13224 2/20 0.50
GRIN2C Q14957 2/20 0.50
OPRD1 P41143 2/20 0.50
DRD3 P35462 2/20 0.50
CACNA1F O60840 1/20 0.50
ABCB1 P08183 1/20 0.50
CYP2B6 P20813 1/20 0.50
DRD4 P21917 1/20 0.50
OPRK1 P41145 1/20 0.50
CACNA1D Q01668 1/20 0.50
KCNH2 Q12809 1/20 0.50
CACNA1S Q13698 1/20 0.50
CACNA1C Q13936 1/20 0.50
MRGPRX2 Q96LB1 1/20 0.50
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9917096 0.95 SLC6A2 (0.43) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
Dipipanone SCHEMBL25367 0.93 OPRM1 (0.57) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
Dipipanone SCHEMBL392119 0.92 OPRM1 (0.56) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
Phenadoxone SCHEMBL25165 0.81 OPRM1 (0.63) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
Phenadoxone SCHEMBL2032631 0.80 OPRM1 (0.62) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
Phenadoxone SCHEMBL9858401 0.78 OPRM1 (0.59) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
SCHEMBL9917084 0.77 GRIN1 (0.84) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
SCHEMBL22313176 0.77 GRIN1 (0.84) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
Phenadoxone SCHEMBL11319633 0.76 OPRM1 (0.57) OPRM1GRIN2DGRIN1GRIN2AGRIN2B
Dipipanone SCHEMBL8741317 0.75 LMNA (0.53) OPRM1GRIN2DGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149900-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-06-14 US disclosed
US-20120149900-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-06-14 US disclosed
WO-2010081034-A2 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149900-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF FLI1, CDC73, FOS OPRM1 2013/4885GRIN2D 1581/4885GRIN1 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.